goal statement, 49
interventions, 49–50
overview, 48
pediatrics
administering medication to pediatric patients,
55
overview, 54–55
pregnant women and fetusus, 54
quiz, 58–59
teaching patient about drugs, 50–51
Nutritional support therapies
enteral nutrition, 185–190
nursing process and, 189–190
nutrition, 183–184
overview, 183, 185, 193–194
parenteral nutrition, 190–193
nursing process and, 192–193
quiz, 194–195
Nylidrin (Arlidin), 369
Nystatin (Mycostatin), 246
O
Ofloxacin (Floxin), 239t
Omeprazole (Prilosec), 343
One-time orders, 16
Opiates, 336
Opioids, 278t
days detectable in urine, 68t
Oral antidiabetics, 394–396
Oral route, 98
Osmolality, 159–160
Osmotic diuretics, 360, 362
Osmotics (saline), 338
Osteoarthritis, 200
Otitis externa, 406
Otitis media, 406
Over-the-counter versus prescription drugs, 7
Oxamniquine (Vansil), 250
Oxazolidones, 294
Oxytetracycline, 233
Oxytetracycline (Terramycin), 234t
P
Pancreas, 391–393, 392t
gestational diabetes mellitus, 393
glucagon, 396
insulin, 393–394
oral antidiabetics, 394–396
signs and symptoms of diabetes mellitus, 393
type I diabetes mellitus, 392
type II diabetes mellitus, 392–393
Papaverine (Cerespan, Genabid), 369
Paraldehyde, 276t
Paramomycin (Humatin)
interaction with vancomycin, 228
Parasympathetic depressants, 283t
Parasympathetic stimulants, 282t
Parathyroid glands, 391
Parenteral medications, 119–121
calculating IV flow rate for continuous or
intermittent (piggyback) infusions,
120–121
heparin infusion, 121
Parenteral nutrition, 190–193
nursing process and, 192–193
Parenteral route
intradermal, 105
intramuscular, 106–107, 108t
overview, 104
subcutaneous, 105–106
Paromomycin (Humatin)
interaction with aminoglycosides, 230
Paroxetine (Paxil), 298, 299t
Patient care plan
deadlines and measurement, 49
evaluation, 50
goal statement, 49
interventions, 49–50
overview, 48
PCP, 70t,76–77
days detectable in urine, 68t
Peak and trough levels, 36
Pediatrics
administering medication to pediatric patients, 55
overview, 54–55
Penicillin, 209–210, 211t–213t,214–215, 407t
drug-drug interactions, 214
nursing diagnosis, 214–215
patient education, 215
Pentazocine, 69t, 311
Pentobarbital (Nembutal)
Peppermint(Menthe piperita), 133
Pepsin inhibitors, 343
Peptic ulcers, 340–341
Perfusion, 254
Peripheral vascular disease, 368–369Index^451